 Norfolk Eastern Daily Press | UK's NICE Rebuffs Glaxo's New Lupus Drug Benlysta Wall Street Journal NICE also said Benlysta should be compared with rituximab, sold by Roche Holding AG (ROG.VX), because some people with severe lupus currently receive rituximab, although it isn't licensed for this use. However, NICE noted there were no reliable data to ... UK cost agency says “no” to GSK's new lupus drug NICE says no to lupus treatment Lupus Drug Rejected By U.K. Health Services |
